DarioHealth Corp. Files 8-K on Director Changes and Compensation
Ticker: DRIO · Form: 8-K · Filed: Apr 21, 2025 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 8-K |
| Filed Date | Apr 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-change, officer-compensation, governance
TL;DR
DarioHealth's 8-K shows director changes and officer compensation updates.
AI Summary
DarioHealth Corp. filed an 8-K on April 21, 2025, reporting on the departure of directors, election of new directors, and compensatory arrangements for officers. The filing also includes financial statements and exhibits. The report covers events up to April 18, 2025.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can signal internal shifts or strategic realignments that may carry inherent risks.
Key Players & Entities
- DarioHealth Corp. (company) — Registrant
- April 18, 2025 (date) — Earliest event reported
- April 21, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- New York (location) — Principal executive office city
FAQ
Who are the departing directors of DarioHealth Corp.?
The filing does not specify the names of the departing directors, only that there was a departure of directors or certain officers.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 18, 2025.
What is the principal executive office address for DarioHealth Corp.?
The principal executive office address is 322 W. 57th St, #33B, New York, New York 10019.
What is the IRS Employer Identification Number for DarioHealth Corp.?
The IRS Employer Identification Number for DarioHealth Corp. is 45-2973162.
What other items are covered in this 8-K filing besides director and officer changes?
This 8-K filing also covers the election of directors, compensatory arrangements of certain officers, and financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 21, 2025 regarding DarioHealth Corp. (DRIO).